Merkel Cell Carcinoma: Epidemiology, Target, and Therapy (Q26824521)

Matthew E. Hardee

2

1 reference

Lynn A. Cornelius

3

1 reference

Laura F. Hutchins

4

1 reference

Jurgen C. Becker

5

1 reference

Ling Gao

6

1 reference

publication date

2014

1 reference

Current dermatology reports

published in

1 reference

volume

3

1 reference

page(s)

46-53

1 reference

Creative Commons Attribution 2.0 Generic

copyright license

start time

22 January 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulator

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3931972

Mammalian Merkel cells are descended from the epidermal lineage

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3931972

Clonal integration of a polyomavirus in human Merkel cell carcinoma

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3931972

Merkel cell carcinoma: prognosis and treatment of patients from a single institution

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3931972

ABT-263 enhances sensitivity to metformin and 2-deoxyglucose in pediatric glioma by promoting apoptotic cell death

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3931972

The intersection of immune-directed and molecularly targeted therapy in advanced melanoma: where we have been, are, and will be.

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3931972

Pathologic nodal evaluation is increasingly commonly performed for patients with Merkel cell carcinoma.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3931972

Palliative treatment for in-transit cutaneous metastases of Merkel cell carcinoma using surface-mold computer-optimized high-dose-rate brachytherapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3931972

Specific analysis of KIT and PDGFR-alpha expression and mutational status in Merkel cell carcinoma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3931972

Isolated limb infusion in a series of over 100 infusions: a single-center experience

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3931972

Emerging and mechanism-based therapies for recurrent or metastatic Merkel cell carcinoma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3931972

Radiotherapy is associated with significant improvement in local and regional control in Merkel cell carcinoma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3931972

Survivin is a therapeutic target in Merkel cell carcinoma.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3931972

Type I and II IFNs inhibit Merkel cell carcinoma via modulation of the Merkel cell polyomavirus T antigens.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3931972

Activation of the PI3K/AKT pathway in Merkel cell carcinoma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3931972

Activation of PI3K signaling in Merkel cell carcinoma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3931972

Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3931972

Complete spontaneous regression of metastatic merkel cell carcinoma: a case report and review of the literature

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3931972

The etiology and epidemiology of merkel cell carcinoma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3931972

A phase II trial of imatinib mesylate in merkel cell carcinoma (neuroendocrine carcinoma of the skin): A Southwest Oncology Group study (S0331)

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3931972

Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3931972

G3139 (Genasense) in patients with advanced merkel cell carcinoma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3931972

Analysis of radiation therapy for the control of Merkel cell carcinoma of the head and neck based on 36 cases and a literature review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3931972

Merkel cell carcinoma: more deaths but still no pathway to blame

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3931972

Merkel cell carcinoma: assessing the effect of wide local excision, lymph node dissection, and radiotherapy on recurrence and survival in early-stage disease--results from a review of 82 consecutive cases diagnosed between 1992 and 2004.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3931972

Absence of classical MAP kinase pathway signalling in Merkel cell carcinoma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3931972

Multimodality treatment of Merkel cell carcinoma: case series and literature review of 1024 cases

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3931972

Chemotherapy in neuroendocrine/Merkel cell carcinoma of the skin: case series and review of 204 cases

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3931972

Trabecular Carcinoma of the Skin

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3931972

Merkel polyomavirus-specific T cells fluctuate with merkel cell carcinoma burden and express therapeutically targetable PD-1 and Tim-3 exhaustion markers

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3931972

Merkel cell polyomavirus in cutaneous swabs

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3931972

Early B-cell differentiation in Merkel cell carcinomas: clues to cellular ancestry

31 May 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13671-014-0068-Z

Epidemiology and survival of Merkel cell carcinoma in the Netherlands. A population-based study of 808 cases in 1993-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13671-014-0068-Z

Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases: a population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13671-014-0068-Z

Sustained Remission of Metastatic Merkel Cell Carcinoma with Treatment of HIV Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13671-014-0068-Z

Merkel cell polyomavirus status is not associated with clinical course of Merkel cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13671-014-0068-Z

Chemotherapy for patients with locally advanced or metastatic Merkel cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13671-014-0068-Z

Effect of radiotherapy dose and volume on relapse in Merkel cell cancer of the skin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13671-014-0068-Z

Adjuvant radiation therapy is associated with improved survival in Merkel cell carcinoma of the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13671-014-0068-Z

Definitive radiotherapy or chemoradiotherapy in the treatment of Merkel cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13671-014-0068-Z

Biotech comes to its 'antisenses' after hard-won drug approval

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13671-014-0068-Z

Response to a novel multitargeted tyrosine kinase inhibitor pazopanib in metastatic Merkel cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13671-014-0068-Z

Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized study.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3931972

28 November 2018

Merkel cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3931972

Platelet-derived growth factor receptor alpha mutational status and immunohistochemical expression in Merkel cell carcinoma: implications for treatment with imatinib mesylate

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3931972

Successful targeted radiotherapy with 90Y-DOTATOC in a patient with Merkel cell carcinoma. A Case Report

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3931972

Use of interferon-alpha in two patients with Merkel cell carcinoma positive for Merkel cell polyomavirus

28 November 2018

1 reference

12 December 2020

Primary neuroendocrine (Merkel cell?) carcinoma of the skin. I. A clinicopathologic and ultrastructural study of 43 cases

1 reference

12 December 2020

Merkel-cell carcinomas in patients treated with methoxsalen and ultraviolet A radiation

1 reference

12 December 2020

Clinical remission of Merkel cell carcinoma after treatment with imatinib

1 reference

12 December 2020

Bcl-2 antisense oligonucleotides (G3139) inhibit Merkel cell carcinoma growth in SCID mice

1 reference

12 December 2020

Peptide receptor radionuclide therapy of Merkel cell carcinoma using (177)lutetium-labeled somatostatin analogs in combination with radiosensitizing chemotherapy: a potential novel treatment based on molecular pathology

1 reference

12 December 2020